{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:00:21Z","timestamp":1755219621639,"version":"3.43.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82371751"],"award-info":[{"award-number":["82371751"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Department of Healthcare in Zhejiang Province","award":["2022481544\/2022RC222"],"award-info":[{"award-number":["2022481544\/2022RC222"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-11450-8","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T06:10:03Z","timestamp":1754547003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sorafenib-treated Th9 cells exhibit superior anti-tumor effect in lung metastasis"],"prefix":"10.1038","volume":"15","author":[{"given":"Fanli","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuowang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jufeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingzhi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"11450_CR1","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.1158\/1078-0432.Ccr-11-0116","volume":"17","author":"SA Rosenberg","year":"2011","unstructured":"Rosenberg, S. A. et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin. Cancer Res. 17, 4550\u20134557. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-11-0116 (2011).","journal-title":"Clin. Cancer Res."},{"key":"11450_CR2","first-page":"501","volume":"1","author":"K Fujita","year":"1995","unstructured":"Fujita, K. et al. Prolonged disease-free period in patients with advanced epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes. Clin. Cancer Res. 1, 501\u2013507 (1995).","journal-title":"Clin. Cancer Res."},{"key":"11450_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/030089160008600109","volume":"86","author":"M Fabbri","year":"2000","unstructured":"Fabbri, M. et al. Tumor infiltrating lymphocytes and continuous infusion interleukin-2 after metastasectomy in 61 patients with melanoma, colorectal and renal carcinoma. Tumori 86, 46\u201352. https:\/\/doi.org\/10.1177\/030089160008600109 (2000).","journal-title":"Tumori"},{"key":"11450_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","volume":"124","author":"H Raskov","year":"2021","unstructured":"Raskov, H., Orhan, A., Christensen, J. P. & G\u00f6genur, I. Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy. Br. J. Cancer 124, 359\u2013367. https:\/\/doi.org\/10.1038\/s41416-020-01048-4 (2021).","journal-title":"Br. J. Cancer"},{"key":"11450_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/nature21724","volume":"544","author":"L Tian","year":"2017","unstructured":"Tian, L. et al. Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming. Nature 544, 250\u2013254. https:\/\/doi.org\/10.1038\/nature21724 (2017).","journal-title":"Nature"},{"key":"11450_CR6","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.121062","author":"Y Sato","year":"2018","unstructured":"Sato, Y. et al. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.121062 (2018).","journal-title":"JCI Insight."},{"key":"11450_CR7","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.90772","volume":"2","author":"JS Bowers","year":"2017","unstructured":"Bowers, J. S. et al. Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion. JCI Insight 2, e90772. https:\/\/doi.org\/10.1172\/jci.insight.90772 (2017).","journal-title":"JCI Insight"},{"key":"11450_CR8","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.90547","author":"K Majchrzak","year":"2017","unstructured":"Majchrzak, K. et al. \u03b2-catenin and PI3K\u03b4 inhibition expands precursor Th17 cells with heightened stemness and antitumor activity. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.90547 (2017).","journal-title":"JCI Insight"},{"key":"11450_CR9","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/nm.3922","volume":"21","author":"IK Kim","year":"2015","unstructured":"Kim, I. K. et al. Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells. Nat. Med. 21, 1010\u20131017. https:\/\/doi.org\/10.1038\/nm.3922 (2015).","journal-title":"Nat. Med."},{"key":"11450_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010073","author":"DSM Chatzileontiadou","year":"2020","unstructured":"Chatzileontiadou, D. S. M., Sloane, H., Nguyen, A. T., Gras, S. & Grant, E. J. The many faces of CD4(+) T Cells: Immunological and structural characteristics. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22010073 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"11450_CR11","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00262-004-0653-2","volume":"54","author":"KL Knutson","year":"2005","unstructured":"Knutson, K. L. & Disis, M. L. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol. Immunother. 54, 721\u2013728. https:\/\/doi.org\/10.1007\/s00262-004-0653-2 (2005).","journal-title":"Cancer Immunol. Immunother."},{"key":"11450_CR12","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.ccell.2024.06.008","volume":"42","author":"Y Lu","year":"2024","unstructured":"Lu, Y. et al. Th9 cells represent a unique subset of CD4(+) T cells endowed with the ability to eradicate advanced tumors. Cancer Cell 42, 1313\u20131314. https:\/\/doi.org\/10.1016\/j.ccell.2024.06.008 (2024).","journal-title":"Cancer Cell"},{"key":"11450_CR13","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3892\/or.2011.1201","volume":"25","author":"T Iida","year":"2011","unstructured":"Iida, T. et al. Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer. Oncol. Rep. 25, 1271\u20131277. https:\/\/doi.org\/10.3892\/or.2011.1201 (2011).","journal-title":"Oncol. Rep."},{"key":"11450_CR14","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1172\/jci124037","volume":"130","author":"Y Salazar","year":"2020","unstructured":"Salazar, Y. et al. Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer. J. Clin. Invest. 130, 3560\u20133575. https:\/\/doi.org\/10.1172\/jci124037 (2020).","journal-title":"J. Clin. Invest."},{"key":"11450_CR15","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/ni.1659","volume":"9","author":"M Veldhoen","year":"2008","unstructured":"Veldhoen, M. et al. Transforming growth factor-beta \u201creprograms\u201d the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9, 1341\u20131346. https:\/\/doi.org\/10.1038\/ni.1659 (2008).","journal-title":"Nat. Immunol."},{"key":"11450_CR16","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1038\/ni.1677","volume":"9","author":"V Dardalhon","year":"2008","unstructured":"Dardalhon, V. et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat. Immunol. 9, 1347\u20131355. https:\/\/doi.org\/10.1038\/ni.1677 (2008).","journal-title":"Nat. Immunol."},{"key":"11450_CR17","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.ccell.2021.09.011","volume":"39","author":"G Xue","year":"2021","unstructured":"Xue, G. et al. Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells. Cancer Cell 39, 1610-1622.e1619. https:\/\/doi.org\/10.1016\/j.ccell.2021.09.011 (2021).","journal-title":"Cancer Cell"},{"key":"11450_CR18","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nrd2130","volume":"5","author":"S Wilhelm","year":"2006","unstructured":"Wilhelm, S. et al. Discovery and development of sorafenib: A multikinase inhibitor for treating cancer. Nat. Rev. Drug Discov. 5, 835\u2013844. https:\/\/doi.org\/10.1038\/nrd2130 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"11450_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2024.101454","volume":"19","author":"Y Shen","year":"2025","unstructured":"Shen, Y. et al. Sorafenib promotes Treg cell differentiation to compromise its efficacy via VEGFR\/AKT\/Foxo1 signaling in hepatocellular carcinoma. Cell Mol. Gastroenterol. Hepatol. 19, 101454. https:\/\/doi.org\/10.1016\/j.jcmgh.2024.101454 (2025).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"11450_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.111872","volume":"133","author":"H Wang","year":"2025","unstructured":"Wang, H. et al. Sorafenib inhibits multiple sclerosis by regulating T cell differentiation. Cell Signal 133, 111872. https:\/\/doi.org\/10.1016\/j.cellsig.2025.111872 (2025).","journal-title":"Cell Signal"},{"key":"11450_CR21","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"key":"11450_CR22","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53, D672-d677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"11450_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"11450_CR24","doi-asserted-by":"publisher","first-page":"15445","DOI":"10.1074\/jbc.M112.340356","volume":"287","author":"A Jash","year":"2012","unstructured":"Jash, A. et al. Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-\u03baB (NF-\u03baB)-mediated interleukin-9 (IL-9) transactivation. J. Biol. Chem. 287, 15445\u201315457. https:\/\/doi.org\/10.1074\/jbc.M112.340356 (2012).","journal-title":"J. Biol. Chem."},{"key":"11450_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aak9741","author":"E Bi","year":"2017","unstructured":"Bi, E. et al. Foxo1 and Foxp1 play opposing roles in regulating the differentiation and antitumor activity of T(H)9 cells programmed by IL-7. Sci. Signal https:\/\/doi.org\/10.1126\/scisignal.aak9741 (2017).","journal-title":"Sci. Signal"},{"key":"11450_CR26","doi-asserted-by":"publisher","first-page":"d49","DOI":"10.2741\/a174","volume":"2","author":"J G\u00f3mez","year":"1997","unstructured":"G\u00f3mez, J., Garc\u00eda-Domingo, D., Mart\u00ednez, A. C. & Rebollo, A. Role of NF-kappaB in the control of apoptotic and proliferative responses in IL-2-responsive T cells. Front. Biosci. 2, d49-60. https:\/\/doi.org\/10.2741\/a174 (1997).","journal-title":"Front. Biosci."},{"key":"11450_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009629","author":"T Chen","year":"2024","unstructured":"Chen, T. et al. Natural lung-tropic T(H)9 cells: A sharp weapon for established lung metastases. J. Immunother. Cancer https:\/\/doi.org\/10.1136\/jitc-2024-009629 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"11450_CR28","doi-asserted-by":"publisher","first-page":"46491","DOI":"10.18632\/oncotarget.14822","volume":"8","author":"X Zhao","year":"2017","unstructured":"Zhao, X. et al. Clinical characteristics and prognoses of patients treated surgically for metastatic lung tumors. Oncotarget 8, 46491\u201346497. https:\/\/doi.org\/10.18632\/oncotarget.14822 (2017).","journal-title":"Oncotarget"},{"key":"11450_CR29","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.1097\/RTI.0b013e3182010bf9","volume":"26","author":"TL Mohammed","year":"2011","unstructured":"Mohammed, T. L. et al. ACR Appropriateness Criteria\u00ae screening for pulmonary metastases. J. Thorac. Imaging 26, W1-3. https:\/\/doi.org\/10.1097\/RTI.0b013e3182010bf9 (2011).","journal-title":"J. Thorac. Imaging"},{"key":"11450_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11071010","author":"GM Stella","year":"2019","unstructured":"Stella, G. M., Kolling, S., Benvenuti, S. & Bortolotto, C. Lung-seeking metastases. Cancers https:\/\/doi.org\/10.3390\/cancers11071010 (2019).","journal-title":"Cancers"},{"key":"11450_CR31","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.ccell.2018.05.004","volume":"33","author":"Y Lu","year":"2018","unstructured":"Lu, Y. et al. Th9 cells represent a unique subset of CD4(+) T cells endowed with the ability to eradicate advanced tumors. Cancer Cell 33, 1048-1060.e1047. https:\/\/doi.org\/10.1016\/j.ccell.2018.05.004 (2018).","journal-title":"Cancer Cell"},{"key":"11450_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nm.4441","volume":"24","author":"TJ Fry","year":"2018","unstructured":"Fry, T. J. et al. CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy. Nat. Med. 24, 20\u201328. https:\/\/doi.org\/10.1038\/nm.4441 (2018).","journal-title":"Nat. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11450-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11450-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11450-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T06:10:05Z","timestamp":1754547005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11450-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11450"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-11450-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"19 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28871"}}